Re: Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
- 1 July 2020
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 78 (1) , 113-114
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trialThe Lancet, 2020
- Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial CarcinomaJournal of Urology, 2019
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateEuropean Urology, 2018
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerEuropean Urology, 2017
- Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate TwinsJournal of Urology, 2013
- Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical SurgeryEuropean Urology, 2012